The Changes in Mean Platelet Volume after Using of Antiplatelet Drugs in Acute XXXX : A Randomized Controlled Trial.

@entity1 @entity64 @entity101 @entity1397 @entity117 @entity25968 @entity4341 @entity1924 @entity6688 @entity385
OBJECTIVE: To measure the changes of mean platelet volume ( @entity6688 ) after using four antiplatelet drugs in acute non-cardioembolic @entity385 @entity1 and assess the association of antiplatelets and @entity6688 and @entity64 outcome. MATERIAL AND METHOD: @entity385 survivors with National Institute of Health @entity64 Scale (NIHSS) 8 were randomly allocated intofour groups, receiving @entity117 , @entity1397 , combined @entity117 and @entity4341 , and @entity1924 . The change of @entity6688 NIHSS, and modified Rankin Scale ( @entity25968 ) were recorded at baseline and week 4 in all studied groups. @entity6688 was measured using the standard automated blood test for complete blood count. RESULTS: Twenty-one subjects were included in this study. They comprised of five cases in each antiplatelet group, except for @entity117 , which had six subjects. Male was 57%, and @entity101 was the most common risk factor (61.9%). Most of @entity1 (76%) had small vessel disease. At 4-week, MPVwas reduced and NIHSS, @entity25968 were improved in every studied group. @entity1397 sign ficantly reduced NIHSS score (p = 0.003), and it produced the greatest reduction in @entity6688 compared to others. CONCLUSION: Every type of antiplatelets included in this study reduced @entity6688 NIHSS, and @entity25968 in acute non- @entity64 @entity1 . @entity1397 improved NIHSS the most.
